Impax Laboratories Inc (IPXL) Slumps On Possible FDA Delay

July 29, 2014 7:48 PM

7 0

Impax Laboratories Inc (IPXL) Slumps On Possible FDA Delay

by Clayton BrowneJuly 29, 2014, 1:59 pm

Small biotech issues can be highly volatile. Impax Laboratories Inc (NASDAQ:IPXL) shares are down around 15% on news today that the FDA sent the company a Form 483 with ten inspectional observations after a general GMP inspection and a Pre-Approval Inspection (PAI) for RYTARY at the Impax’s Taiwan m...

Read more

To category page

Loading...